Lemaitre Vascular (LMAT) Short-term Investments (2017 - 2026)

Lemaitre Vascular (LMAT) has reported Short-term Investments for 10 consecutive years, with $340.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 22.79% year-over-year to $340.4 million; the TTM figure through Mar 2026 stood at $340.4 million (up 22.79% YoY), while the FY2025 annual figure was $330.9 million, up 20.71% from the prior year.
• Short-term Investments grew to $340.4 million in Q1 2026 per LMAT's latest filing, from $330.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $340.4 million in Q1 2026 and bottomed at $54.9 million in Q2 2022.
• Historically, Short-term Investments has averaged $155.3 million across 5 years, with a median of $81.7 million in 2024.
• On a YoY basis, Short-term Investments climbed as much as 25751.4% in 2022 and fell as far as 13.28% in 2022.
• Lemaitre Vascular's Short-term Investments stood at $63.6 million in 2022, then advanced by 27.14% to $80.8 million in 2023, then soared by 239.23% to $274.1 million in 2024, then gained by 20.71% to $330.9 million in 2025, then advanced by 2.87% to $340.4 million in 2026.
• Business Quant data shows LMAT's Short-term Investments at $340.4 million in Q1 2026, $330.9 million in Q4 2025, and $317.6 million in Q3 2025.